药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Pralsetinib
Pralsetinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
4-Bromo-2,5-dimethoxyamphetamine
Ripretinib
Ripretinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
4-Bromo-2,5-dimethoxyamphetamine
Fedratinib
Fedratinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
4-Bromo-2,5-dimethoxyamphetamine
Nabiximols
Nabiximols may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
4-Bromo-2,5-dimethoxyamphetamine
Medical Cannabis
Medical Cannabis may decrease the excretion rate of Delafloxacin which could result in a higher serum level.